OrthoPediatrics Corp. to Attend International Children’s Spine Symposium

Author:

OrthoPediatrics Corp., a company dedicated to advancing the field of pediatric orthopedics, has announced its participation in the 8th Annual International Children’s Spine Symposium (ICSS). The event, organized by the Armstrong Children’s Orthopedic Alliance, will take place on April 5th and 6th in Denver, Colorado.

During the symposium, OrthoPediatrics will showcase its RESPONSE™ portfolio for Scoliosis surgery, which offers an advanced system of instruments and implants that provide enhanced versatility and improved patient outcomes. The company will also feature its Rib and Pelvic Fixation system, designed for treating kids with Early Onset Scoliosis, as well as the ApiFix technology, a non-fusion alternative for patients with Adolescent Idiopathic Scoliosis (AIS).

In addition to highlighting its product offerings, OrthoPediatrics has provided educational grants to hospitals and institutions for senior residents and fellows to attend the symposium.

David Bailey, OrthoPediatrics’ President & CEO, expressed his pride in being the lead sponsor of ICSS. He views the symposium as an important platform for engaging with pediatric orthopedic fellows and attending surgeons, providing them with training on the latest technologies and surgical techniques.

OrthoPediatrics was founded in 2006 and is dedicated to improving the lives of children with orthopedic conditions. The company offers a comprehensive product range in trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization focuses exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries worldwide.

For more information about OrthoPediatrics, please visit www.orthopediatrics.com.

Investor Contact:
Philip Trip Taylor
Gilmartin Group
[email protected]
415-937-5406

OrthoPediatrics Corp. operates in the field of pediatric orthopedics, which specializes in treating orthopedic conditions in children. The company offers a comprehensive range of products in trauma and deformity, scoliosis, and sports medicine/other procedures. They are dedicated to improving the lives of children with orthopedic conditions and have a global sales organization that focuses exclusively on pediatric orthopedics.

One of the company’s notable offerings is the RESPONSE™ portfolio for Scoliosis surgery. This advanced system of instruments and implants provides enhanced versatility and improved patient outcomes. OrthoPediatrics will showcase this portfolio at the 8th Annual International Children’s Spine Symposium (ICSS), organized by the Armstrong Children’s Orthopedic Alliance.

In addition to the RESPONSE™ portfolio, OrthoPediatrics will feature its Rib and Pelvic Fixation system, designed for treating kids with Early Onset Scoliosis. They will also present the ApiFix technology, which offers a non-fusion alternative for patients with Adolescent Idiopathic Scoliosis (AIS).

OrthoPediatrics’ participation in the ICSS demonstrates their commitment to staying at the forefront of pediatric orthopedics. The company’s President & CEO, David Bailey, considers the symposium an essential platform for engaging with pediatric orthopedic fellows and attending surgeons. It provides valuable training on the latest technologies and surgical techniques in the field.

OrthoPediatrics has also gone a step further by providing educational grants to hospitals and institutions. These grants enable senior residents and fellows to attend the symposium, further promoting knowledge-sharing and advancements in the field of pediatric orthopedics.

As a leading company in the industry, OrthoPediatrics distributes its products not only in the United States but also in over 70 countries worldwide. This global reach allows them to make a significant impact on the lives of children with orthopedic conditions around the world.

For more information about OrthoPediatrics and their offerings, please visit their website at www.orthopediatrics.com.

Investor Contact:
Philip Trip Taylor
Gilmartin Group
[email protected]
415-937-5406